Clinically-Collected Specimens
BioIVT has the expertise in the processes required for ethical acquisition of biospecimens that cover a wide range of disease states and the protocols needed to produce reliable data. With over 425 IRB-approved clinical sites, BioIVT provides clinical specimens for nearly all disease states.
Clinically-Collected Specimens
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
BioIVT has the expertise in the processes required for ethical acquisition of biospecimens that cover a wide range of disease states and the protocols needed to produce reliable data. With over 425 IRB-approved clinical sites, BioIVT provides clinical specimens for nearly all disease states, such as:
- Oncology tissues with board-certified pathology confirmation of diagnosis
- Pre- and post-treatment biofluids
- Infectious disease/serology cohorts with confirmed or suspected diagnosis
- Clinical remnant samples with associated clinical data and test results representing autoimmune, cardiovascular, dermatological, neurological and endocrine diseases, among others
Mutation analysis is also available with around 10,000 specimens with next-generation sequencing (NGS) data and the capacity to screen 600+ biospecimens per month.
TechTalk: Crucial Starting Material Considerations for NAM Success
Friday, September 25 at 16:00 BST | 17:00 CEST | 11:00 EDT | 08:00 PDT
With industry and regulatory leaders placing greater emphasis on New Approach Methodologies (NAMs), researchers need starting materials that support human relevance, reproducibility, and confidence from the outset.
In this 20-minute SelectScience® TechTalk, Dr. Courtney Noah, Vice President of Scientific Affairs at BioIVT, will explore how ethically sourced and well-characterized human specimens can influence the success of NAM development.
The session will examine how donor variability, fit-for-purpose quality control, standardization, and documentation can help researchers generate more reliable nonclinical data and de-risk NAM workflows from the start.
Certificate of attendance
If you attend the live TechTalk, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand TechTalk, you can request a certificate of attendance by emailing editor@selectscience.net.
TechTalk details
- Cost: Free to attend
- Location: Online
- Duration: 20 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on-demand recording once it becomes available.
Modeling immune related adverse events in preclinical research
In this guest editorial, Dr. Courtney Noah, BioIVT's Vice President of Scientific Affairs, explores why disease state donors and purified immune subsets improve predictive safety models
Training AI to accurately identify biomarkers in tumor biospecimens
Guest editorial by Courtney Noah, Ph.D., and Daryl Waggott, MSc
